VC firms
Edit

WuXi Healthcare Ventures

http://wuxiventures.com
Last activity: 05.10.2017
Probably Closed
Mentions
17

Overview

Investment Type
Venture Capital
Investment Stage
Series A

Funds raised 1

DateFund sizeAnnouncement
Sign up to seeSign up to seeSign up to see

Mentions in press and media 17

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Sep 18, 2017LifeMine Therapeutics Closes $55M Series ALifeMine Therapeutics today announced the closing of a $55 million Series A financing. The round was led by WuXi Healthcare Ventures with an investor syndicate comprised of Foresite Capital, GV (formerly Google Ventures), Arch Ventures, Boy...
Sep 18, 2017Arch Ventures Joins $55M Series A for LifeMine TherapeuticsLifeMine Therapeutics today announced the closing of a $55 million Series A financing. The round was led by WuXi Healthcare Ventures with an investor syndicate comprised of Foresite Capital, GV (formerly Google Ventures), Arch Ventures, Boy...
May 31, 2017$420M fund comes to LYFE, with plans for a trans-Pa­cif­ic in­vest­ment strat­e­gy in­tro­duc­ing US biotechs to Chi­naLess than two years af­ter its launch, Shang­hai-based LYFE Cap­i­tal has come up with an up­sized biotech ven­ture fund. And this time it’s spread­ing its wings di­rect­ly in­to the US mar­ket, where it plans to start mak­ing some new bets...
May 29, 2017Ge Li melds WuXi VC with Front­line, cre­at­ing an $800M trans-Pa­cif­ic pow­er­house fund now hunt­ing fresh biotech cap­i­talWuXi’s Ge Li is lever­ag­ing up a whole new biotech ven­ture group with am­bi­tious plans to add to the hun­dreds of mil­lions of dol­lars it’s in­vest­ed in glob­al biotechs. Ge Li Ge Li is throw­ing in his port­fo­lio of 40 biotechs at Wu...
Jul 4, 2016Chinese biopharma firm CStone gets $150m Series A from Oriza, Boyu, WuXiPremium Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures have jointly invested in a bio-pharmaceutical firm CStone Pharmaceuticals’ series A financing round of $150 million, the companies said in a statement. Continue r...
Jul 3, 2016CStone Pharmaceuticals Receives $150M in Series A from WuXi HealthcareCStone Pharmaceuticals Co., Ltd (CStone), a bio-pharmaceutical company devoted to developing new treatments in a range of therapeutic areas, announced that it has closed its Series A round of 150 million dollars financing (about 975 million...
May 11, 2016WuXi Healthcare Ventures Adds Gregory Verdine as Newest Venture PartnerWuXi Healthcare Ventures, a Shanghai and Boston-based cross-border venture capital firm focused on the life sciences and healthcare fields, has added Gregory Verdine, Ph.D., as its newest Venture Partner. Dr. Verdine, Erving Professor at Ha...
Feb 7, 201623andMe’s position on genomic diversity, international expansionEthnicity? Predominantly Western European, 23andMe President Andy Page said in an interview. Part of that, of course, is because most of its million-plus users are stateside. However, 23andMe plans on international expansion – to broaden th...
Jan 29, 2016China’s Qiming Venture Partners closing $650M fund, reaches $600M in healthcare investmentsThe company says it has invested more than $600 million in the healthcare sector in the past seven years. In 2014, it invested in a dozen healthcare startups, offering an average of $10 million to each, it said in a statement. “Qiming curre...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about WuXi Healthcare Ventures

What funds has WuXi Healthcare Ventures raised?

WuXi Healthcare Ventures has announced 1 fund on Parsers VC.

What has the press written about WuXi Healthcare Ventures?

Parsers VC has collected 17 articles mentioning WuXi Healthcare Ventures, among them “LifeMine Therapeutics Closes $55M Series A” (Sep 18, 2017) and “Arch Ventures Joins $55M Series A for LifeMine Therapeutics” (Sep 18, 2017).

Is WuXi Healthcare Ventures still active?

WuXi Healthcare Ventures is probably closed: its latest activity on Parsers VC dates from Oct 5, 2017.